The current pregnant women living with hiv antiretroviral therapy coverage for pmtct of Yemen is 24%, an increase of 17% (242.9%) compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Yemen
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Yemen
PMTCT antiretroviral therapy coverage
More indicators for Yemen
Male unintentional poisoning
2.2
+0.3
(2019)
Female wasting in children
14.8%
+3.1%
(2013)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar83
-intl dollar43
(2015)
Birth registration
30.7%
+13.6%
(2013)
Contraceptive modern method prevalence
29.2%
+9.6%
(2013)
Yemen PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 24% | +17% |
| 2021 | 7% | +4% |
| 2020 | 3% | -4% |
| 2019 | 7% | +4% |
| 2018 | 3% | 0% |
| 2017 | 3% | +3% |
| 2016 | 0% | -2% |
| 2015 | 2% | -3% |
| 2014 | 5% | -2% |
| 2013 | 7% | +2% |
| 2012 | 5% | +2% |
| 2011 | 3% | -6% |
| 2010 | 9% | +2% |
| 2009 | 7% | +6% |
| 2008 | 1% | 0% |
| 2007 | 1% | +1% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |